Bachem Holding AG
BANB
株式のランク
#2516
Bachem Holding AG serves pharmaceutical and biotechnology companies globally,... Bachem Holding AG serves pharmaceutical and biotechnology companies globally, providing products crucial for research, clinical development, and commercial use. The company's primary focus is on the design, manufacturing, and regulatory support for peptide active pharmaceutical ingredients (APIs), specifically targeting novel peptide and oligonucleotide chemical entities (NCEs). Additionally, Bachem offers commercially available NCEs and generic compounds. Its comprehensive service portfolio includes project management, quality assurance and regulatory guidance, analytical testing, production adhering to Good Manufacturing Practices (GMP), manufacturing for research purposes, and expertise in supply chain and vertical integration. Established in 1971, Bachem Holding AG is headquartered in Bubendorf, Switzerland, and functions as a subsidiary of Ingro Finanz AG.
株価
$100.60
時価総額
$7.54B
変化（1日）
-1.49%
変化（1年）
49.53%
国
CH
取引 Bachem Holding AG (BANB)
カテゴリー
Healthcare
Bachem Holding AG（BANB）の利益
2026 時点の利益 TTM: 0
Bachem Holding AG の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Bachem Holding AG の利益の推移（2002 〜 2026）
各年末の利益
| 年 | 利益 | 変化 |
|---|---|---|
| 2025 | $197.08M | 31.67% |
| 2024 | $149.68M | 1.35% |
| 2023 | $147.69M | 21.84% |
| 2022 | $121.22M | -15.88% |
| 2021 | $144.11M | 42.32% |
| 2020 | $101.26M | 62.26% |
| 2019 | $62.40M | 12.36% |
| 2018 | $55.54M | 11.92% |
| 2017 | $49.63M | 10.07% |
| 2016 | $45.08M | 20.90% |
| 2015 | $37.29M | 1.92% |
| 2014 | $36.59M | 12.98% |
| 2013 | $32.38M | 52.96% |
| 2012 | $21.17M | 62.51% |
| 2011 | $13.03M | -61.93% |
| 2010 | $34.22M | -23.54% |
| 2009 | $44.76M | -29.32% |
| 2008 | $63.33M | -12.95% |
| 2007 | $72.75M | 49.11% |
| 2006 | $48.79M | 30.20% |
| 2005 | $37.47M | 1.17% |
| 2004 | $37.04M | -5.60% |
| 2003 | $39.24M | 21.47% |
| 2002 | $32.30M | 0.00% |
同業他社の利益
| 企業 | 利益 | 利益の差 | 国 |
|---|---|---|---|
| $5.27B | - |
US
|
|
| $-3.09B | - |
US
|
|
| $-4.02B | - |
AU
|
|
| $1.95B | - |
NL
|
|
| - | - |
CH
|
